FOI release

Freedom of Information request - Sustanon Licencing information

Some or all of the information requested may not have been provided because we required clarification from the requester.

Case reference FOI2025/01324

Received 23 December 2025

Published 2 February 2026

Request

Please provide me with any documents, internal and external communications and other information relating to the 2001 approval of Sustanon 250 for the treatment of female to male transsexualism.

Response

See attached

Documents

• FOI2025_01324 (redacted).pdf (674.9 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.